Table of Contents

HK J Paediatr (New Series)
Vol 29. No. 2, 2024

HK J Paediatr (New Series) 2024;29:100-104

Case Report

Use of Sirolimus in Managing Protein-Losing Enteropathy: A Case Study of Noonan Syndrome in a Chinese Adolescent

CSY Chan, STY Lui, APY Liu, ACC Fu


Abstract

Noonan syndrome is an autosomal dominant genetic disorder which causes malformation of the lymphatic system, leading to lymphangiectasia of the intestines and protein-losing enteropathy. We report a case of a 15-year-old Chinese girl with PTPN11-mutation Noonan syndrome with recurrent lower limb oedema and hypoalbuminaemia. Multiple targeted investigations confirmed the diagnosis of lymphangiectasia leading to protein-losing enteropathy, including a Tc99m human serum albumin, an oesophageoduodenoscopy with biopsy, and magnetic resonance lymphangiogram showing features of central conducting lymphatic anomaly with abnormal lymphatic flow. Being refractory to conventional treatment strategies, initiation of Sirolimus, an m-TOR inhibitor, yielded satisfactory clinical improvement in this patient. This case demonstrated the diagnostic complexity and management challenge in patients with protein-losing enteropathy caused by lymphangiectasia, which is one of the rare complications in Noonan syndrome. Early commencement of Sirolimus with close monitoring of side effects is helpful in disease control and symptom resolution.

Keyword : Noonan syndrome; Protein-losing enteropathy; Sirolimus


 
 

This web site is sponsored by Johnson & Johnson (HK) Ltd.
©2024 Hong Kong Journal of Paediatrics. All rights reserved. Developed and maintained by Medcom Ltd.